Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
O14520
UPID:
AQP7_HUMAN
Alternative names:
Aquaglyceroporin-7; Aquaporin adipose; Aquaporin-7-like
Alternative UPACC:
O14520; Q08E94; Q5T5L9; Q8NHM3
Background:
Aquaporin-7, also known as Aquaglyceroporin-7, Aquaporin adipose, and Aquaporin-7-like, is a pivotal protein that forms channels across cell membranes, facilitating the transport of water, glycerol, and urea at neutral pH. This protein is integral to the body's energy homeostasis, especially during lipid catabolism, by mediating glycerol export from adipocytes and supporting gluconeogenesis in the liver to maintain blood glucose levels.
Therapeutic significance:
Understanding the role of Aquaporin-7 could open doors to potential therapeutic strategies, particularly in managing conditions related to energy metabolism and glycerol transport.